Drug monitoring – Immunosuppressant Latest Update

The NanoDem project is reaching its conclusion with the successful development of a prototype analyser.  Partners met in Munich Nov 28 to Dec 1st for the final review meeting which involved assessment by the EC project officer.  Clinical evaluations will take place during the summer 2017 on receiving ethics committee approval which is expected any…
Read more »

Nanodem – Immunosuppressant monitoring

Mark O’Connell will be presenting at the forthcoming NANODEM meeting 28th Nov to Dec 1st. A proposal for ethics approval has been submitted and clinical work is planned to commence in the new year. Probe’s MicroEye forms the basis of the patient interface for the therapeutic drug monitoring project which is studying immunosuppressant levels continuously…
Read more »

ICS State of the Art 2016 (5-7 December ExCel London)

Probe will be exhibiting at the ICS State of the Art meeting in December. We will be showing our systems for continuous glucose and lactate monitoring We will be discussing the importance and practicality of automated monitoring, delivering better data without the need for constant attention. We will also be interested to hear from anyone…
Read more »

Sepsis Unplugged

The UK Sepsis Trust ‘Sepsis Unplugged’ Conference 2016 Hosted by The UK Sepsis Trust, this conference will bring together all healthcare professions and patient groups as equals and will ask the questions which will help shape better care for patients with sepsis. Probe will be exhibiting at “ Sepsis Unplugged” in Brighton from the 13th…
Read more »

SUCCESSFUL volunteer studies

Probe has recently conducted a number of successful volunteer studies at it Bedford laboratories. These studies will continue throughout the autumn during which time Probe will be recruiting additional clinical partners for the next stage of studies.    

Neil Smith CEO of Probe will be attending ESICM October 2nd –October 5th.

Neil Smith CEO of Probe will be attending ESICM October 2nd –October 5th. The European Society of Intensive Care Medicine is an Association of individual persons. The ESICM was founded in March 1982 in Geneva, Switzerland. It is a non-profit making international association. ESICM supports and promotes the advancement of knowledge in intensive care medicine,…
Read more »

Advances in antibiotics therapy in the critically ill.

A recent paper by Jean Louis Vincent shows how important continuous therapeutic drug monitoring will be. Infections occur frequently in critically ill patients and their management can be challenging for various reasons, including delayed diagnosis, difficulties identifying causative microorganisms, and the high prevalence of antibiotic-resistant strains. In this review, we briefly discuss the importance of…
Read more »

Latest publication on Interstitial fluid for glucose control

Use of interstitial fluid in tight glycaemic control in ICU is not without risk.  Dr Mark O’Connell comments on a recent paper. Read full article The inherent weakness in all systems that rely on measuring interstitial fluid glucose (e.g. under the skin devices) is that they need clever algorithms to try to predict blood glucose. …
Read more »